GAMMA Investing’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$370K Sell
2,194
-198
-8% -$33K 0.01% 886
2026
Q2
$380K Buy
2,392
+259
+12% +$38.5K 0.01% 809
2026
Q1
$313K Buy
2,133
+238
+13% +$36.7K 0.01% 818
2025
Q4
$293K Buy
1,895
+10
+0.5% +$1.5K 0.01% 779
2025
Q3
$262K Buy
1,885
+26
+1% +$3.52K 0.01% 810
2025
Q2
$251K Buy
1,859
+843
+83% +$114K 0.02% 769
2025
Q1
$148K Hold
1,016
– – 0.01% 942
2024
Q4
$140K Hold
1,016
– – 0.01% 893
2024
Q3
$156K Hold
1,016
– – 0.02% 736
2024
Q2
$148K Buy
1,016
+497
+96% +$71.3K 0.02% 601
2024
Q1
$76.7K Buy
519
+289
+126% +$41.5K 0.02% 772
2023
Q4
$32.3K Buy
+230
New +$29.9K 0.01% 1190

Other funds holding XLV

GAMMA Investing's XLV Position: Q3 2026 in Review

GAMMA Investing reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 8.3% in Q3 2026, selling an estimated $33K and leaving 2,194 shares worth $370K. The position accounts for 0.01% of the portfolio, ranked #886.

GAMMA Investing first reported a position in XLV in Q4 2023 and has held it in 12 quarters since. The position peaked at $380K in Q2 2026. 101 funds tracked by Wall St. Rank hold XLV as of Q3 2026.

  • GAMMA Investing held 2,194 shares of State Street Health Care Select Sector SPDR ETF worth $370K as of Q3 2026.
  • GAMMA Investing sold 198 State Street Health Care Select Sector SPDR ETF shares in Q3 2026, an estimated $33K.
  • State Street Health Care Select Sector SPDR ETF made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #886 holding.
  • GAMMA Investing first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's State Street Health Care Select Sector SPDR ETF position peaked at $380K in Q2 2026.
  • 101 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.